Debridement offers no advantage in treating microsporidial keratoconjunctivitis
Corneal debridement showed no distinct advantage in resolving corneal lesions and improving vision in eyes treated for microsporidial keratoconjunctivitis, a study found. The prospective, double-masked, randomized study included 120 patients with clinical features indicative of microsporidial superficial keratoconjunctivitis. Fifty-eight patients underwent debridement, and 62 patients underwent conjunctival swabbing. All patients received ocular lubricants.